Tecnobios Procreazione, Centre for Reproductive Health, Bologna, Italy.
Fertil Steril. 2010 Oct;94(5):1662-8. doi: 10.1016/j.fertnstert.2009.10.029. Epub 2010 Jan 4.
To evaluate the efficacy of oocyte cryopreservation by a single slow-cooling protocol involving sucrose (0.2 mol/L) in the freezing solution.
Observational comparison of the clinical outcome in fresh and frozen thawed cycles.
Public and private IVF centers.
PATIENT(S): Infertile couples undergoing IVF treatment.
INTERVENTION(S): Use of a maximum three oocytes in fresh cycles, as established by local law, and cryopreservation and later use of surplus oocytes. Likewise fresh cycles, maximum three thawed oocytes were used per cycle. All thawed oocytes were microinjected.
MAIN OUTCOME MEASURE(S): Embryologic and clinical parameters of fresh and thawed cycles.
RESULT(S): Two thousand forty-six patients underwent 2,209 oocyte retrievals involving oocyte cryopreservation. Overall, the survival rate of thawed oocytes was 55.8%. In 940 thaw cycles, the mean numbers of inseminated oocytes and fertilization rates were significantly decreased vs. fresh cycles outcomes (2.6 ± 0.7 vs. 2.9 ± 0.2 and 72.5% vs. 78.3%, respectively), as were the rates of implantation (10.1% vs. 15.4%), pregnancy rates per transfer (17.0% vs. 27.9%), and pregnancy rates per cycle (13.7% vs. 26.2%). Differences in clinical outcome were found among centers. A pregnancy rate per thawing cycle above 14% was achieved by most clinics. Fifty-seven retrievals involving oocyte cryopreservation achieved a pregnancy after fresh embryo replacement. Implantation and pregnancy rates per embryo transfer and per thawing cycles were 17.5%, 28.6%, and 24.6%, respectively.
CONCLUSION(S): Under the conditions tested, the clinical outcome of oocyte slow-cooling cryopreservation is reduced compared with fresh cycles. Nevertheless, in cases of inapplicability of embryo cryopreservation, oocyte cryopreservation should be offered to patients with surplus oocytes.
评估在冷冻液中使用蔗糖(0.2mol/L)的单一慢速冷却方案对卵母细胞冷冻保存的疗效。
新鲜和冷冻解冻周期临床结局的观察性比较。
公共和私人试管婴儿中心。
接受试管婴儿治疗的不孕夫妇。
使用当地法律规定的最大 3 个卵母细胞进行新鲜周期,并进行卵母细胞冷冻保存,然后使用多余的卵母细胞。同样,每个新鲜周期最多使用 3 个解冻卵母细胞。所有解冻的卵母细胞均进行了微注射。
新鲜和解冻周期的胚胎学和临床参数。
2046 名患者接受了 2209 次卵母细胞采集,涉及卵母细胞冷冻保存。总体而言,解冻卵母细胞的存活率为 55.8%。在 940 个解冻周期中,与新鲜周期相比,受精的卵母细胞数量和受精率显著降低(分别为 2.6±0.7 与 2.9±0.2 和 72.5%与 78.3%),胚胎着床率(10.1%与 15.4%)、每个移植的妊娠率(17.0%与 27.9%)和每个周期的妊娠率(13.7%与 26.2%)也降低。不同中心之间的临床结局存在差异。大多数中心的解冻周期妊娠率超过 14%。57 次涉及卵母细胞冷冻保存的采集在新鲜胚胎替换后获得妊娠。每个胚胎移植和每个解冻周期的胚胎着床率和妊娠率分别为 17.5%、28.6%和 24.6%。
在测试条件下,卵母细胞慢速冷却冷冻保存的临床结局与新鲜周期相比降低。然而,在胚胎冷冻不适用的情况下,应向有多余卵母细胞的患者提供卵母细胞冷冻保存。